Field-specific AI agents accelerate workflows in the life sciences sector.
Eureka LS Suite is a collection of support tools consisting of five AI agents specialized for the pharmaceutical and biotech industries, focusing on drug discovery, intellectual property, competitive analysis, and antibody research. Based on vast amounts of life sciences data such as patents, literature, market information, and sequences, it achieves efficiency in daily operations and accelerates decision-making. AI addresses the information processing challenges faced by experts. **Features** - A group of AI agents specialized in the life sciences field: With a modular structure that caters to specialized tasks in the biotech and pharmaceutical industries, such as drug discovery, antibodies, patents, and competitive research, it delivers outputs directly linked to practical work. - A high-precision database that is updated daily: Life sciences-specific data, including clinical trial and approved drug information, patents, and literature, is continuously updated to ensure analysis accuracy and reliability. - Q&A and document analysis in natural language: The interface is designed to be intuitive, allowing users to operate in a question format without needing specialized knowledge. - Support for unstructured data, automatically extracting insights from vast amounts of information: It can process documents in various formats, including PDFs, reports, and news articles. *For more details, please request a catalog or contact us with your inquiries.*
Inquire About This Product
Related Videos
basic information
Each agent can be utilized as an AI partner that is "ready to use" in practical applications, designed to meet the needs of on-site operations. ■Pharma Insights Advisor An AI agent that provides highly reliable answers to Q&A related to drug discovery, clinical trials, and competitive intelligence in just seconds. ■Pharma Document Analyzer Extracts trends and key points from pharmaceutical-related documents (PDFs, reports, news, etc.). Processes summarization, tagging, and insight extraction in one go, reducing review time for large amounts of information. ■Markush Claim Drafting Agent Efficiently creates Markush structures and patent claims for new compounds. ■Pharma Competitor Intelligence Explorer Analyzes the origins, patents, and market conditions of approved drugs. Reports on patent expirations, exclusivity periods, and regional trends in real-time, contributing to product strategy. ■Antibody-Target Predictor Assists in screening antibody candidates and predicting targets. Analyzes epitopes, sequences, and affinities to reduce HTP screening costs and support increased success rates in antibody development.
Price range
Delivery Time
Applications/Examples of results
■Pharma Insights Advisor Accelerates information gathering in drug development, CI, and clinical trial Q&A, reducing decision-making time by 3–5 hours per week. ■Pharma Document Analyzer Creates trend analysis and summaries of documents, reducing information organization and review work by 3–5 hours per week. ■Markush Claim Drafting Generates drafts of Markush claims with one click, potentially reducing patent drafting time by up to 80%. ■Pharma Competitor Intelligence Explorer Facilitates easy investigation and monitoring of the origins of approved drugs, contributing to the identification of market entry, product launch, and research and development opportunities, thereby reducing costs associated with external consultants. ■Antibody-Target Predictor Reduces costs for HTP screening and antibody selection, staying ahead of competitors while mitigating downstream risks in antibody development potential.
catalog（2）
Download All Catalogs
Company information
Patocoa Inc. is a specialized company in drug discovery support systems. Additionally, we focus on improving and streamlining compliance-related operations concerning regulated substances, and we have provided various solutions to pharmaceutical companies, chemical companies, universities, and government agencies. We contribute to accelerating drug discovery and reducing costs with our cutting-edge chemoinformatics systems.
